CN Patent
CN100526315C — N2-喹啉或异喹啉取代的嘌呤衍生物及其制备方法和其用途
Assigned to Zhejiang Medicine Co Ltd · Expires 2009-08-12 · 17y expired
What this patent protects
本发明公开了一种N 2 -喹啉或异喹啉取代的嘌呤衍生物,以及含有所述化合物的药物组合物。本发明的化合物具有毒性低、抗癌谱广、抗癌活性高、稳定性好等特点。可用于制备抗肿瘤药物,本发明公开了它们的制备方法。
USPTO Abstract
本发明公开了一种N 2 -喹啉或异喹啉取代的嘌呤衍生物,以及含有所述化合物的药物组合物。本发明的化合物具有毒性低、抗癌谱广、抗癌活性高、稳定性好等特点。可用于制备抗肿瘤药物,本发明公开了它们的制备方法。
Drugs covered by this patent
- Copiktra (DUVELISIB) · Secura
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.